Literature DB >> 12195325

Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial.

P Sauer1, J Hansmann, G M Richter, W Stremmel, A Stiehl.   

Abstract

BACKGROUND AND STUDY AIMS: After a first variceal bleeding episode in patients with cirrhosis of the liver, treatment with transjugular intrahepatic portosystemic stent shunt (TIPS) and endoscopic variceal ligation (EVL) plus propranolol were compared, with regard to prevention of variceal rebleeding, complications, and mortality. PATIENTS AND METHODS: 85 patients were randomly allocated to receive TIPS (n = 43) or EVL (n = 42). The groups were comparable regarding age, sex, etiology of liver cirrhosis, and liver function.
RESULTS: The mean observation times were 4.1 years in the TIPS group and 3.6 years in the EVL group. Although the probability of rebleeding was higher in the EVL group (29.9%) than in the TIPS group (19.4%), the difference was not statistically significant. Three of five patients of the EVL group successfully underwent TIPS placement after treatment failure. The probability of TIPS dysfunction requiring shunt revision was 89 %. Hepatic encephalopathy was observed more often in the TIPS group (40.5%) than in the EVL group (20.5%; P < 0.05). The probability of survival was similar in both groups (TIPS group 75.9%, EVL group 82.2%; n.s.).
CONCLUSIONS: In view of its good efficacy and the lower cost of treatment, endoscopic ligation plus propranolol may be recommended as initial procedure for prevention of recurrent variceal hemorrhage, whereas TIPS seems to be the preferable procedure in patients with recurrent bleeding after adequate endoscopic and pharmacological treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195325     DOI: 10.1055/s-2002-33565

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  13 in total

Review 1.  Mortality from cirrhosis: lack of progress over the last 35 years.

Authors:  C Gluud
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

Review 2.  Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review.

Authors:  Xing-Shun Qi; Ming Bai; Zhi-Ping Yang; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

3.  TIPS versus endoscopic therapy for variceal rebleeding in cirrhosis: A meta-analysis update.

Authors:  Hu Zhang; Hui Zhang; Hui Li; Heng Zhang; Dan Zheng; Chen-Ming Sun; Jie Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

Review 4.  Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis.

Authors:  S Khan; C Tudur Smith; P Williamson; R Sutton
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

5.  Radiofrequency ablation for hypersplenism in patients with liver cirrhosis: a pilot study.

Authors:  Quanda Liu; Kuansheng Ma; Zhenping He; Jiahong Dong; Xin Hua; Xuequan Huang; Liang Qiao
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

Review 6.  Transjugular intrahepatic portosystemic shunt.

Authors:  Kavish R Patidar; Malcolm Sydnor; Arun J Sanyal
Journal:  Clin Liver Dis       Date:  2014-08-27       Impact factor: 6.126

7.  Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center.

Authors:  Jian-Ping Qin; Ming-De Jiang; Wen Tang; Xiao-Ling Wu; Xin Yao; Wei-Zheng Zeng; Hui Xu; Qian-Wen He; Ming Gu
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

8.  Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.

Authors:  Maria Corina Plaz Torres; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Davide Roccarina; Amine Benmassaoud; Laura Iogna Prat; Norman R Williams; Mario Csenar; Dominic Fritche; Tanjia Begum; Sivapatham Arunan; Maxine Tapp; Elisabeth Jane Milne; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-03-30

9.  The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status.

Authors:  Gilles Pomier-Layrargues; Louis Bouchard; Michel Lafortune; Julien Bissonnette; Dave Guérette; Pierre Perreault
Journal:  Int J Hepatol       Date:  2012-07-19

10.  Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.

Authors:  Rosa G Simonetti; Giovanni Perricone; Helen L Robbins; Narendra R Battula; Martin O Weickert; Robert Sutton; Saboor Khan
Journal:  Cochrane Database Syst Rev       Date:  2020-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.